ExoCoBio is based in Seoul, South Korea. It has raised $47M in total funding. Latest round: Series C.
ExoCoBio funding overview
ExoCoBio is based in Seoul, South Korea. ExoCoBio has raised $47M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series C announced in September 2018. The round record for ExoCoBio runs through 2018; nothing later has been disclosed. Investors on record include Seven Tree Equity Partners, CSQUARED Global Asset Management, TS Investment Partners, K2 Investment, Intervest, KDB Capital and 6 others. 12 distinct backers are named across the disclosed rounds.
ExoCoBio has raised $47M in total disclosed funding across the rounds on record.
Who has invested in ExoCoBio?
Seven Tree Equity Partners, CSQUARED Global Asset Management, TS Investment Partners, K2 Investment, Intervest, KDB Capital are named among the investors backing ExoCoBio.
What was the latest ExoCoBio funding round?
The most recent disclosed round is a Series C, announced in September 2018.
Where is ExoCoBio based?
ExoCoBio is based in Seoul, South Korea.
When did ExoCoBio last raise?
The last disclosed ExoCoBio round closed in September 2018 at Series C.
Every ExoCoBio figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Seoul at a similar stage.
